Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wessels

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Bioanalysis|January 11, 2019
Use of Ella<sup>®</sup> to facilitate drug quantification and antidrug antibody detection in preclinical studiesUwe Wessels, Klaus Mackeben, Kay Stubenrauch
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2009
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primatesKay Stubenrauch, Uwe Wessels, Helmut Lenz
Analytical Biochemistry|April 22, 2009
Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standardsKay Stubenrauch, Uwe Wessels, Rudolf Vogel, et al.
Bioanalysis|September 3, 2025
Selective IgM digestion improves anti-AAV IgG detection in the immune complex assay formatUwe Wessels, Alexander Pöhler, Francesca Ros, et al.
Bioanalysis|May 1, 2020
Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragmentOlaf Broders, Uwe Wessels, Markus Zadak, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 20, 2010
Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodiesKay Stubenrauch, Uwe Wessels, Ulrich Essig, et al.
Clinical Therapeutics|October 27, 2010
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testingKay Stubenrauch, Uwe Wessels, Herbert Birnboeck, et al.
The AAPS Journal|November 22, 2022
Preclinical Observations of Systemic and Ocular Antidrug Antibody Response to Intravitreally Administered DrugsUwe Wessels, Markus Zadak, Anja Manuela Weidmann, et al.
Bioanalysis|May 19, 2017
Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutationUwe Wessels, Eginhard Schick, Mirko Ritter, et al.
Bioanalysis|March 18, 2024
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity controlUwe Wessels, Florian Neff, Julia Fakhiri, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Bioanalysis|January 11, 2019
Use of Ella<sup>®</sup> to facilitate drug quantification and antidrug antibody detection in preclinical studiesUwe Wessels, Klaus Mackeben, Kay Stubenrauch
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2009
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primatesKay Stubenrauch, Uwe Wessels, Helmut Lenz
Analytical Biochemistry|April 22, 2009
Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standardsKay Stubenrauch, Uwe Wessels, Rudolf Vogel, et al.
Bioanalysis|September 3, 2025
Selective IgM digestion improves anti-AAV IgG detection in the immune complex assay formatUwe Wessels, Alexander Pöhler, Francesca Ros, et al.
Bioanalysis|May 1, 2020
Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragmentOlaf Broders, Uwe Wessels, Markus Zadak, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 20, 2010
Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodiesKay Stubenrauch, Uwe Wessels, Ulrich Essig, et al.
Clinical Therapeutics|October 27, 2010
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testingKay Stubenrauch, Uwe Wessels, Herbert Birnboeck, et al.
The AAPS Journal|November 22, 2022
Preclinical Observations of Systemic and Ocular Antidrug Antibody Response to Intravitreally Administered DrugsUwe Wessels, Markus Zadak, Anja Manuela Weidmann, et al.
Bioanalysis|May 19, 2017
Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutationUwe Wessels, Eginhard Schick, Mirko Ritter, et al.
Bioanalysis|March 18, 2024
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity controlUwe Wessels, Florian Neff, Julia Fakhiri, et al.
Pageof 3